Literature DB >> 6155969

Failure of interferon to modify Creutzfeldt-Jakob disease.

J Kovanen, M Haltia, K Cantell.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 6155969      PMCID: PMC1601054          DOI: 10.1136/bmj.280.6218.902-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Creutzfeldt-Jakob disease with focal onset unsuccessfully treated with amantadine.

Authors:  J Ratcliffe; A Rittman; S Wolf; M A Verity
Journal:  Bull Los Angeles Neurol Soc       Date:  1975-01

2.  Interferon crosses blood-cerebrospinal fluid barrier in monkeys.

Authors:  D V Habif; R Lipton; K Cantell
Journal:  Proc Soc Exp Biol Med       Date:  1975-05

3.  Unconventional viruses and the origin and disappearance of kuru.

Authors:  D C Gajdusek
Journal:  Science       Date:  1977-09-02       Impact factor: 47.728

4.  Familial Creutzfeldt-Jakob disease.

Authors:  M Haltia; J Kovanen; H Van Crevel; G T Bots; S Stefanko
Journal:  J Neurol Sci       Date:  1979-08       Impact factor: 3.181

5.  An attempt to modify scrapie in mice by the administration of interferon.

Authors:  I Gresser; I H Pattison
Journal:  J Gen Virol       Date:  1968-09       Impact factor: 3.891

  5 in total
  4 in total

Review 1.  Rapidly progressive dementias and the treatment of human prion diseases.

Authors:  Brian S Appleby; Constantine G Lyketsos
Journal:  Expert Opin Pharmacother       Date:  2010-11-23       Impact factor: 3.889

Review 2.  Prions: Beyond a Single Protein.

Authors:  Alvin S Das; Wen-Quan Zou
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

3.  Familial Creutzfeldt-Jakob disease in Finland: epidemiological, clinical, pathological and molecular genetic studies.

Authors:  M Haltia; J Kovanen; L G Goldfarb; P Brown; D C Gajdusek
Journal:  Eur J Epidemiol       Date:  1991-09       Impact factor: 8.082

Review 4.  Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.

Authors:  R B Pollard
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.